- Medicamen Biotech
Medicamen Biotech Share Price
NSE: MEDICAMEQ
|BSE: 531146
|Pharmaceuticals
₹412.50
+₹1.15 (0.28%) Last updated on 18 Jun, 2025 | 15:29 ISTMedicamen Biotech Overview
Market cap  ₹558 Crs | Open ₹414.00 | Prev. Close ₹411.35 |
Circuit range ₹493.60 - ₹329.10 | Day range ₹407.70 - ₹417.75 | Year range ₹375.05 - ₹630.00 |
Volume 14,160 | Avg. traded ₹413.40 | Revenue (12m) ₹163 Crs |
About Medicamen Biotech
Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industry. The Company’s focus areas include antibiotics, hypertension, general pain management, cardiovascular, diabetics and oncology formulations. In cardiology, the Company is delivering effective treatments for heart-related conditions. Its CNS products address neurological disorders, while its diabetology solutions focus on advanced diabetes management. It also contributes to the global fight against malaria with its anti-malarial medications. Additionally, the Company offers essential vitamins, antibiotics for bacterial infections, and comprehensive pain management solutions. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, and others.
Medicamen Biotech Share Price Chart
Please wait...
Medicamen Biotech Key Indicators
P/E ratio 64.34 | P/B ratio 2.32 | ROE 6.85% |
ROCE 10.13% | Dividend yield 0.23% | Debt/Equity ratio 0.15 |
EPS 10.46 |
Investment Checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Medicamen Biotech Financial Ratios
Operating profit margin17.14% | Net profit margin7.71% |
ROE6.85% | ROA4.69% |
ROCE10.13% |
Quick ratio1.25 | Current ratio1.85 |
Interest coverage3.99 | Asset turnover0.61 |
Debt to Equity0.15 |
P/E ratio64.34 | P/B ratio2.32 |
EV / EBITDA17 | |
Dividend yield0.23% |
Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-24 | ₹179.31 | ₹25.84 | ₹9.49 |
Mar-23 | ₹140.87 | ₹26.80 | ₹14.73 |
Mar-22 | ₹115.45 | ₹25.81 | ₹14.90 |
Mar-21 | ₹112.72 | ₹20.43 | ₹12.13 |
Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-24 | ₹-6.74 | ₹-5.56 | |
Mar-23 | ₹-6.29 | ₹-5.88 | |
Mar-22 | ₹-8.47 | ||
Mar-21 | ₹-17.81 |
Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-24 | ₹292.04 | ₹85.05 |
Mar-23 | ₹276.64 | ₹83.22 |
Mar-22 | ₹225.20 | ₹78.73 |
Mar-21 | ₹194.01 | ₹61.12 |
Medicamen Biotech Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
18-Jun-25 | ₹414.00 | ₹412.50 | |
17-Jun-25 | ₹407.50 | ₹411.35 | |
16-Jun-25 | ₹415.75 | ₹409.65 | -0.75% |
13-Jun-25 | ₹415.00 | ₹412.75 | -1.40% |
12-Jun-25 | ₹427.50 | ₹418.60 | -1.51% |
11-Jun-25 | ₹424.25 | ₹425.00 | |
10-Jun-25 | ₹425.95 | ₹421.45 | -0.07% |
09-Jun-25 | ₹424.10 | ₹421.75 | -0.55% |
Corporate Actions
Dividend • ₹1/share
Ex date 19 Sep 2024
Dividend • ₹1/share
Ex date 20 Sep 2023
Stocks Similar to Medicamen Biotech
Stock Name | Price | Change % |
|---|---|---|
| Bajaj Healthcare | ₹530.50 | -₹2.35 (-0.44%) |
| Kopran | ₹189.80 | -₹0.77 (-0.4%) |
| Neuland Lab | ₹12,267.00 | -₹265.00 (-2.11%) |
| NGL Fine Chem | ₹998.00 | -₹20.30 (-1.99%) |
| ORCHID PHARMA | ₹691.35 | -₹10.60 (-1.51%) |
| Panacea Biotec | ₹428.75 | -₹8.60 (-1.97%) |
| SMS Pharmaceuticals | ₹248.55 | -₹3.50 (-1.39%) |
| Suven Life Sciences | ₹235.26 | -₹1.69 (-0.71%) |
| Unichem Laboratories | ₹574.10 | -₹15.70 (-2.66%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| Indian Railway Finance Corp | ₹136.02 | -₹1.81 (-1.31%) |
| Indian Railway Tourism Corp | ₹759.70 | -₹9.00 (-1.17%) |
| ITC | ₹415.90 | -₹1.50 (-0.36%) |
| JIO FIN SERVICES LTD | ₹288.15 | -₹1.65 (-0.57%) |
| NTPC | ₹332.40 | -₹2.80 (-0.84%) |
| Reliance | ₹1,430.10 | -₹1.10 (-0.08%) |
| Tata Motors | ₹670.25 | -₹4.50 (-0.67%) |
| Tata Power | ₹393.40 | -₹2.65 (-0.67%) |
| Tata Steel | ₹152.11 | -₹0.49 (-0.32%) |
| YES Bank | ₹19.89 | -₹0.05 (-0.25%) |
Medicamen Biotech News
FAQs on Medicamen Biotech
What is the share price of Medicamen Biotech today?
Medicamen Biotech share price is ₹ 412.50 as on 18 Jun, 2025 | 15:29 IST.
What are the high & low stock price of Medicamen Biotech today?
Medicamen Biotech stock price hit a high of ₹ 417.75 and low of ₹ 407.70 as on 18 Jun, 2025 | 15:29 IST.
What is the market cap of Medicamen Biotech?
The market cap of Medicamen Biotech is ₹ 557.91 Crores as on 18 Jun, 2025 | 15:29 IST.
What are the the 52-week high and low share prices of Medicamen Biotech stock on the NSE?
52-week high stock Price of Medicamen Biotech is ₹ 630.00 and Low Price is ₹ 375.05 as on 18 Jun, 2025 | 15:29 IST.
What are the stock symbols of Medicamen Biotech?
The stock symbol of Medicamen Biotech is NSE: MEDICAMEQ on the NSE, BSE: 531146 on the BSE, and the ISIN is INE646B01010.
Can I buy Medicamen Biotech shares on Holidays?
No, shares of Medicamen Biotech or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Medicamen Biotech shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Medicamen Biotech?
The PE and PB ratio of Medicamen Biotech is 64.34 and 2.32 respectively, as on 18 Jun, 2025 | 15:29 IST.
What are the returns on Medicamen Biotech shares?
The historical returns for Medicamen Biotech shares are -14.19 for 1 year, -32.58 for 3 year and -25.48 for 5 year.